Merck, 4104, Centrifree® Ultrafiltration Centrifugal Filters

General description
Separation of free from bound microsolute in serum, plasma, and other biological samples
Determine free therapeutic drugs, testosterone, thyroxin
Binding studies
New drug investigations
Deproteinization
For research and in vitro diagnostic use

The Centrifree® Ultrafiltration device with Ultracel regenerated cellulose membrane is ideal for separating free from bound microsolutes in serum, plasma, and other biological samples. The device is licensed for research use and in vitro diagnostic use. The device holds a sample volume of 1 mL with a hold-up volume of 10 µL.
PL
The Centrifree® Ultrafiltration device with Ultracel regenerated cellulose membrane is ideal for separating free from bound microsolutes in serum, plasma, and other biological samples. The device is licensed for research use and in vitro diagnostic use. The device holds a sample volume of 1 mL with a hold-up volume of 10 µL.

Features & Benefits:
•Separate unbound (free) therapeutic drugs, testosterone, thyroxin, etc.
•Enables accuracy in binding studies
•Critical for new drug investigations
•Facilitates deproteinization to reduce complexity or matrix interference of biological samples
•For research and in vitro diagnostic use

Applications:
Determination of Free Drugs, Testosterone, Thyroxin or Other Bioactives, Binding Studies, New Drug Investigations
Ultrafiltration
Features and Benefits
50 µL
Physical form
Clear
Legal Information
CENTRIFREE is a registered trademark of Merck KGaA, Darmstadt, Germany
ULTRACEL is a registered trademark of Merck KGaA, Darmstadt, Germany